Major Shareholding Notification • Nov 22, 2021
Major Shareholding Notification
Open in ViewerOpens in native device viewer
Information réglementée
IBA (Ion Beam Application), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to the notification received on November 15th, 2020.
In its notification, Norges Bank announces that, following a sale of voting shares, its shareholding in IBA SA has fallen below the 2% threshold for shares with voting rights.
| A) Voting rights | Previous notification | After the transaction | ||||
|---|---|---|---|---|---|---|
| # of voting rights | # of voting rights | % of voting rights | ||||
| Holders of voting rights | Linked to securities | Not linked to the securities |
Linked to securities |
Not linked to the securities |
||
| Norges Bank | 1.110.771 | 668,964 | 1.75% | |||
| TOTAL | 668,964 | 1.75% | $0.00\%$ |
IBA | Ion Beam Applications SA
1
Information réglementée
| B) Equivalent financial instruments | After the transaction | |||||||
|---|---|---|---|---|---|---|---|---|
| Holders of equivalent financial instruments |
Type of financial instrument | Expiration date | Exercise period or date |
# of voting rights that may be acquired if the instrument is exercised |
% of voting rights | Settlement | ||
| TOTAL | 0 | $0.00\%$ | ||||||
| đ The totals will be updated once you have clicked on |
||||||||
| TOTAL (A & B) | # of voting rights % of voting rights |
Norges Bank is the central bank of Norway. As part of its central bank activities, Norges Bank manages Norway's foreign exchange reserves and is responsible for management of the Norwegian Government Pension Fund Global (GPFG). The formal responsibility for management of the GPFG is placed with the Ministry of Finance, but is delegated to Norges Bank. All investments are executed by Norges Bank acting as principal and all holdings are registered in the name of Norges Bank.
IBA
Valérie Van Impe Paralegal +32 10 203 180 [email protected]
IBA (Ion Beam Applications) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The company is the worldwide technology leader in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA's proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room solutions. In addition, IBA also has a radiation dosimetry business and develops particle
IBA | Ion Beam Applications SA
Chemin du Cyclotron, 3 | 1348 Louvain-la-Neuve | Belgium | RPM Brabant-wallon VAT : BE 0428.750.985 | T +32 10 47 58 11 | F +32 10 47 58 10 [email protected] | iba-worldwide.com
2
Information réglementée
accelerators for the medical world and industry. Headquartered in Belgium and employing about 1,500 people worldwide, IBA has installed systems across the world.
IBA is listed on the pan-European stock exchange NYSE EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB). More information can be found at: www.iba-worldwide.com
Communiqué de presse |
IBA | Ion Beam Applications SA
Chemin du Cyclotron, 3 | 1348 Louvain-la-Neuve | Belgium | RPM Brabant-wallon VAT : BE 0428.750.985 | T +32 10 47 58 11 | F +32 10 47 58 10 [email protected] | iba-worldwide.com
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.